Inhalon Biopharma, Inc. — Form D/A
Inhalon Biopharma, Inc. of CARRBORO, NC, a company, filed a Form D amendment with the SEC on 2020-09-17. The offering totals $3.6M, of which $2.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-09-17
- Form: D/A
- Accession: 0001822334-20-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.6M
- Amount sold: $2.9M
- Remaining: $725K
- Investors: 15
- Date of first sale: 2020-08-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-374195
Issuer
- Name: Inhalon Biopharma, Inc.
- CIK: 0001822334
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 106 OAK SPRING COURT, CARRBORO, NC, 27510
- Phone: (650) 439-0110
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Samuel B Lai | Director | Carrboro, NC |
| Winnie B Wan | Director | Carrboro, NC |
| John B Whelan | Director | Carrboro, NC |
| Samuel B Lai | Executive Officer | Carrboro, NC |
| John B Whelan | Executive Officer | Carrboro, NC |
Other filings by this issuer (1)
More